| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3140 |
| Trial ID | NCT05480449 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | huCART19 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy) |
| Year | 2022 |
| Country | United States |
| Company sponsor | Stephan Grupp MD PhD |
| Other ID(s) | 22-019978|22CT011 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||||
|
|||||||||||||